These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2118718)
1. Effect of blood-brain barrier disruption on the permeability of peritumoral edema. Sato S; Toya S; Ohtani M; Suga S; Harada S; Ikeda Y Adv Neurol; 1990; 52():555. PubMed ID: 2118718 [No Abstract] [Full Text] [Related]
2. Quantitative magnetic resonance imaging assessment of mannitol's effect on peritumoral brain edema. Boisvert DP; Lazareff JA; Allen PS Adv Neurol; 1990; 52():560. PubMed ID: 2118719 [No Abstract] [Full Text] [Related]
3. Experimental peritumoral edema of the cat brain. Hossmann KA; Blöink M; Wilmes F; Wechsler W Adv Neurol; 1980; 28():323-40. PubMed ID: 7457250 [No Abstract] [Full Text] [Related]
4. [Blood-brain barrier opening microcirculation in human brain tumor]. Sato S; Toya S; Otani M No To Shinkei; 1985 Feb; 37(2):109-13. PubMed ID: 2988587 [TBL] [Abstract][Full Text] [Related]
5. [Studies on the blood-brain barrier with a fluorescent tracer in human brain edema]. Ginsbourg M; Foncin JF; Le Beau J C R Seances Soc Biol Fil; 1970; 164(12):2443-6. PubMed ID: 4258339 [No Abstract] [Full Text] [Related]
7. [Pathological mechanisms, prevention and treatment of brain edema in the light of recent studies]. Kunicki A Neurol Neurochir Pol; 1975; 9(5):659-65. PubMed ID: 1186959 [No Abstract] [Full Text] [Related]
11. Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke. Chen CH; Toung TJ; Sapirstein A; Bhardwaj A J Cereb Blood Flow Metab; 2006 Jul; 26(7):951-8. PubMed ID: 16306935 [TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier disruption and methotrexate in the treatment of a readily transplantable intracerebral osteogenic sarcoma of rats. Cosolo W; Christophidis N Cancer Res; 1987 Dec; 47(23):6225-8. PubMed ID: 3119195 [TBL] [Abstract][Full Text] [Related]
14. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors. Neuwelt EA; Hill SA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Lewis SE; Ehle AL; Beyer CW Cancer Treat Rep; 1981; 65 Suppl 2():39-43. PubMed ID: 6809316 [TBL] [Abstract][Full Text] [Related]
15. The molecular mechanism of dexamethasone-mediated effect on the blood-brain tumor barrier permeability in a rat brain tumor model. Gu YT; Qin LJ; Qin X; Xu F Neurosci Lett; 2009 Mar; 452(2):114-8. PubMed ID: 19135131 [TBL] [Abstract][Full Text] [Related]